Because fibroblasts from SSc patients are rare and difficult to obtain in large quantities, we set up a model of myofibroblasts using TGFβ1-mediated stimulation of dermal fibroblasts from healthy donors (H-Fb). Here, TGFB1 is linked to systemic sclerosis.